These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 8289989)
1. In vitro approach to 'uremic cardiomyopathy'. Weisensee D; Löw-Friedrich I; Riehle M; Bereiter-Hahn J; Schoeppe W Nephron; 1993; 65(3):392-400. PubMed ID: 8289989 [TBL] [Abstract][Full Text] [Related]
2. Potential uremic toxins modulate energy metabolism of cardiac myocytes in vitro. Weisensee D; Schnaars Y; Schoeppe W; Bereiter-Hahn J; Löw-Friedrich I Exp Nephrol; 1997; 5(3):194-200. PubMed ID: 9208278 [TBL] [Abstract][Full Text] [Related]
3. Mitochondrial dysfunction in uremic cardiomyopathy. Taylor D; Bhandari S; Seymour AM Am J Physiol Renal Physiol; 2015 Mar; 308(6):F579-87. PubMed ID: 25587120 [TBL] [Abstract][Full Text] [Related]
4. The effects of uremic compounds on cardiac function and metabolism. Scheuer J; Stezoski W J Mol Cell Cardiol; 1973 Jun; 5(3):287-300. PubMed ID: 4720519 [No Abstract] [Full Text] [Related]
5. Effects of cytokines on the contractility of cultured cardiac myocytes. Weisensee D; Bereiter-Hahn J; Schoeppe W; Löw-Friedrich I Int J Immunopharmacol; 1993 Jul; 15(5):581-7. PubMed ID: 8375940 [TBL] [Abstract][Full Text] [Related]
7. Uremic cardiomyopathy and insulin resistance: a critical role for akt? Semple D; Smith K; Bhandari S; Seymour AM J Am Soc Nephrol; 2011 Feb; 22(2):207-15. PubMed ID: 20634295 [TBL] [Abstract][Full Text] [Related]
8. [Cardiomyopathy in uremia: hemodynamic and metabolic aspects (author's transl)]. Drüeke T; Le Pailleur C Nephrologie; 1981; 2(2):63-6. PubMed ID: 7290302 [TBL] [Abstract][Full Text] [Related]
9. Uremic toxicity: present state of the art. Vanholder R; Argilés A; Baurmeister U; Brunet P; Clark W; Cohen G; De Deyn PP; Deppisch R; Descamps-Latscha B; Henle T; Jorres A; Massy ZA; Rodriguez M; Stegmayr B; Stenvinkel P; Wratten ML Int J Artif Organs; 2001 Oct; 24(10):695-725. PubMed ID: 11817319 [TBL] [Abstract][Full Text] [Related]
10. Uremic cardiomyopathy: studies on cardiac function in the guinea pig. Kersting F; Brass H; Heintz R Clin Nephrol; 1978 Sep; 10(3):109-13. PubMed ID: 699407 [TBL] [Abstract][Full Text] [Related]
12. Uremic toxins: a new focus on an old subject. Yavuz A; Tetta C; Ersoy FF; D'intini V; Ratanarat R; De Cal M; Bonello M; Bordoni V; Salvatori G; Andrikos E; Yakupoglu G; Levin NW; Ronco C Semin Dial; 2005; 18(3):203-11. PubMed ID: 15934967 [TBL] [Abstract][Full Text] [Related]
13. Uremic cardiomyopathy is characterized by loss of the cardioprotective effects of insulin. Semple DJ; Bhandari S; Seymour AM Am J Physiol Renal Physiol; 2012 Nov; 303(9):F1275-86. PubMed ID: 22914780 [TBL] [Abstract][Full Text] [Related]
14. Effects of uremic serum on isolated cardiac myocyte calcium cycling and contractile function. Periyasamy SM; Chen J; Cooney D; Carter P; Omran E; Tian J; Priyadarshi S; Bagrov A; Fedorova O; Malhotra D; Xie Z; Shapiro JI Kidney Int; 2001 Dec; 60(6):2367-76. PubMed ID: 11737612 [TBL] [Abstract][Full Text] [Related]
19. Effect of verapamil on uremic myocardial disease in the rat. Zahavi I; Chagnac A; Djaldetti M; Katz M; Levi J J Submicrosc Cytol; 1985 Oct; 17(4):637-44. PubMed ID: 4078949 [TBL] [Abstract][Full Text] [Related]
20. The red blood cell as a model for the study of uremic toxins. Smith EK; Welt LG Arch Intern Med; 1970 Nov; 126(5):827-30. PubMed ID: 4248903 [No Abstract] [Full Text] [Related] [Next] [New Search]